Frovatriptan use while Breastfeeding

Drugs containing Frovatriptan: Frova

Medically reviewed on September 8, 2017

Frovatriptan Levels and Effects while Breastfeeding

Summary of Use during Lactation

No published experience exists with frovatriptan during breastfeeding. If frovatriptan is required by the mother, it is not a reason to discontinue breastfeeding. However, because frovatriptan has a long half-life of 25 to 30 hours, a shorter-acting alternate drug may be preferred, especially while nursing a newborn or preterm infant.[1]

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Sumatriptan, Eletriptan

References

1. Amundsen S, Nordeng H, Nezvalova-Henriksen K et al. Pharmacological treatment of migraine during pregnancy and breastfeeding. Nat Rev Neurol. 2015;11:209-19. PMID: 25776823

Frovatriptan Identification

Substance Name

Frovatriptan

CAS Registry Number

158747-02-5

Drug Class

Serotonin Agonists

Administrative Information

LactMed Record Number

577

Disclaimer

Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer